Guardant Health, Inc. (NAS: GH) Stock Analysis & Fundamentals | ScreenerHero

Create free account

GHGuardant Health, Inc.

NAS · US · Healthcare · Diagnostics & Research · guardanthealth.com

155.00USD-4.88%Mkt Cap: 20.55B $P/E: —1d ago

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutati…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap20.55B $

Enterprise Value21.15B $

Revenue (TTM)1.08B $

Gross Profit633.01M $

Net Income (TTM)-416.28M $

Revenue/Share8.491 USD

Last Price155.00 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees2.5K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS40131M1099

Valuation

P/E (Trailing)—

P/E (Forward)-357.80

PEG—

EV/EBITDA-51.83

EV/Revenue19.58

P/S19.03

P/B-112.56

EPS (TTM)-3.41

EPS (Forward)-0.43

52W Range

40.3587% of range172.83

52W High172.83 USD

52W Low40.35 USD

Profitability

Gross Margin64.46%

Oper. Margin-40.23%

EBITDA Margin-37.79%

Profit Margin-42.39%

ROE419.18%

ROA-20.67%

Growth

Revenue Growth48.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-184.76M $

CapEx (TTM)48.31M $

FCF Margin-7.91%

FCF Yield-0.42%

Net Debt601.80M $

Net Debt/EBITDA-1.47

Balance Sheet

Debt/Equity-17.22

Current Ratio4.68

Quick Ratio4.25

Book Value/Sh-1.3770 USD

Cash/Share8.316 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)169.00 USD

Upside (mean)+9.0%

Target Range90.00 USD – 215.00 USD

$90.00+9.0% to mean$215.00

# Analysts24

Ownership

Shares Out.132.60M

Float127.84M

Insiders4.02%

Institutions106.07%

Short Interest

Short Ratio3.9d

Short % Float9.55%

Short % Out.9.16%

Shares Short12.14M

Short (prev mo.)13.21M

Technical

SMA 50128.84 (+20.3%)

SMA 200102.05 (+51.9%)

Beta1.59

S&P 52W Chg20.25%

Avg Vol (30d)2.74M

Avg Vol (10d)2.86M

Technical Indicators

RSI (14)57.8

MACD9.7046

MACD Signal10.8284

MACD Hist.-1.1237

BB Upper180.56 USD

BB Middle150.59 USD

BB Lower120.63 USD

BB Width39.80%

ATR (14)7.809 USD

Vol Ratio (20d)0.88x